Oncology Institute (DFPH) Assets Average (2020 - 2026)

Oncology Institute (DFPH) has 7 years of Assets Average data on file, last reported at $166.4 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 1.14% year-over-year to $166.4 million; the trailing twelve-month figure through Mar 2026 stood at $166.4 million (down 1.14% YoY), and the FY2025 full-year result was $168.7 million, down 11.67% from the prior year.
• Assets Average for Q1 2026 stood at $166.4 million, up from $164.1 million in the prior quarter.
• Across five years, Assets Average topped out at $272.7 million in Q4 2022 and bottomed at $161.7 million in Q3 2025.
• The 5-year median for Assets Average is $198.1 million (2022), against an average of $200.5 million.
• The widest annual swing landed in 2022, when Assets Average soared 38.16%; it then slipped 21.61% in 2023.
• A 5-year view of Assets Average shows it stood at $272.7 million in 2022, then fell by 21.61% to $213.8 million in 2023, then retreated by 17.7% to $176.0 million in 2024, then decreased by 6.71% to $164.1 million in 2025, then increased by 1.4% to $166.4 million in 2026.
• The last three Assets Average figures came in at $166.4 million (Q1 2026), $164.1 million (Q4 2025), and $161.7 million (Q3 2025), per Business Quant data.

Peer Comparison